907 related articles for article (PubMed ID: 26054795)
1. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
2. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
Schver GCRM; Lee PI
Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
[TBL] [Abstract][Full Text] [Related]
3. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
4. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
Sun DD; Lee PI
Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
[TBL] [Abstract][Full Text] [Related]
5. Evolution of supersaturation from amorphous solid dispersions in water-insoluble polymer carriers: Effects of swelling capacity and interplay between partition and diffusion.
Schver GCRM; Nadvorny D; Lee PI
Int J Pharm; 2020 May; 581():119292. PubMed ID: 32243967
[TBL] [Abstract][Full Text] [Related]
6. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
Ojo AT; Ma C; Lee PI
Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
[TBL] [Abstract][Full Text] [Related]
8. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
[TBL] [Abstract][Full Text] [Related]
9. Tailoring supersaturation from amorphous solid dispersions.
Li N; Taylor LS
J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
[TBL] [Abstract][Full Text] [Related]
10. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
Dukeck R; Sieger P; Karmwar P
Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
[TBL] [Abstract][Full Text] [Related]
11. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
12. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
Han YR; Lee PI
Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
[TBL] [Abstract][Full Text] [Related]
13. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
14. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
16. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
17. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
18. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
19. The Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions.
Punčochová K; Ewing AV; Gajdošová M; Pekárek T; Beránek J; Kazarian SG; Štěpánek F
Pharm Res; 2017 May; 34(5):990-1001. PubMed ID: 27573574
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique.
Park JH; Choi HK
Arch Pharm Res; 2015 Jul; 38(7):1336-44. PubMed ID: 25567762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
